FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
3,819 letters. Newest first.
-
FoodLXR Biotech, LLC
FDA warns LXR Biotech over CGMP (manufacturing quality rules) failures for Eternal Energy supplements, making them adulterated (legally unfit as made).
Medium -
DrugsChemspec Chemicals Private Limited
FDA warns Indian API maker Chemspec Chemicals over missing batch records and data integrity failures.
High risk -
DrugsPurushothaman Damodara Kumaran, M.D. / Senthil Specialty Hospital
FDA warned Senthil Specialty Hospital and Dr. Purushothaman Damodara Kumaran about missed safety monitoring in a bioequivalence study of an investigational drug.
High risk -
DevicesASP Global, LLC. dba Anatomy Supply Partners, LLC.
FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.
High risk -
FoodPan-African Food Distributors Inc./East Africa Boutique LLC
FDA found widespread rodent and insect infestation in Pan-African Food Distributors’ warehouse holding dietary supplements, foods and cosmetics.
High risk -
FoodMiddle East/Soli's Baking Company, Inc. dba Middle East Baking Co.
FDA found live insects and rodent droppings throughout Middle East Baking's pita and bagel plant in Burlingame, California.
High risk -
Tobaccosnuzyn.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccobongsociety.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsAbsolutely Natural
FDA warned Absolutely Natural of Melbourne, Florida, over nonprescription drug manufacturing violations, including weak contamination investigations and component testing.
High risk -
DrugsTower Laboratories Ltd.
FDA warned Tower Laboratories, an OTC drug maker in Montague, MI, for weak out-of-specification investigations and unproven test methods.
High risk -
DrugsLiquidCapsule Manufacturing, LLC
LiquidCapsule Manufacturing failed CGMP (current good manufacturing practice) for OTC drugs, including component identity testing and process validation failures.
High risk -
DrugsAgebox Inc.
Agebox Inc. sells iKids-Growth children's supplements containing the undeclared, unapproved drug ibutamoren, making them unapproved and misbranded drugs.
High risk -
DrugsUnipack LLC
FDA says Unipack LLC released suppositories without adequate out-of-specification investigations, complete lab records, and required USP testing.
High risk -
DrugsPrivate Label Skin Care, Inc.
FDA warned Private Label Skin Care about poor quality oversight, continued sale of impurity-affected over-the-counter drugs, and missing drug listings.
High risk -
DevicesPalamur Biosciences Private Limited
FDA warns Palamur Biosciences over GLP violations in medical device safety testing and inadequate corrective actions.
High risk -
DrugsDevalingam Mahalingam, M.D., Ph.D.
FDA warns clinical investigator Devalingam Mahalingam, M.D., Ph.D. over a 100-fold investigational drug overdose that led to a subject's death.
High risk -
Tobaccosmokespotvape.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsGuangdong Renhe Guozhuang Biotechnology Co., Ltd.
FDA warns Guangdong Renhe Guozhuang Biotechnology over CGMP failures in OTC drug manufacturing.
High risk -
DrugsAtomix LLC
FDA warned Atomix LLC that its website sells unapproved SARM drugs MK-2866 and RAD-140 as new drugs without approval.
High risk -
DrugsPrime Sports Nutrition
FDA warns Prime Sports Nutrition that its website sells SARMs such as LGD-4033 and RAD-140 as unapproved new drugs.
High risk -
DrugsPinnacle Professional Research dba Pinnacle Peptides
FDA told Pinnacle Peptides its SARMs sold online are unapproved new drugs with serious safety risks.
High risk -
DrugsDynamic Health Group dba SARMS AMERICA
FDA told SARMS AMERICA its SARMs products (Ostarine, MK-677, Cardarine, LGD-4033) are unapproved new drugs sold online without FDA approval.
High risk -
DrugsTITAN SARMS LLC
Titan SARMS LLC sells SARM capsules (LGD-4033, RAD-140, S-4, YK-11) as unapproved new drugs, FDA says after website review.
High risk -
DrugsMaria A. Carballosa, M.D.
FDA warns Dr. Maria Carballosa over failure to retain clinical trial records for an investigational drug.
Medium -
DrugsMedinatura New Mexico, Inc.
FDA cited Medinatura New Mexico for drug manufacturing rule violations, including weak component testing and cleaning.
High risk -
DrugsSV Labs Corporation
SV Labs released microbe-contaminated OTC drug products and lacked water, process and quality controls, FDA says.
High risk -
DrugsDarmerica, LLC
FDA warns Darmerica over manufacturing-quality violations and mislabeled drug ingredients, including retatrutide.
High risk -
AnimalKing Farm
King Farm's horse feed held fumonisin up to 36.1 ppm; FDA ties it to at least 30 horse deaths.
High risk -
DrugsRevive Rx LLC dba Revive Rx Pharmacy
FDA warns Revive Rx Pharmacy over insanitary production of sterile compounded drugs, citing contamination risks.
High risk -
DevicesTG Supply LLC d/b/a TransGuy Supply
FDA warned TransGuy Supply that its breast binders are unregistered, unlisted medical devices.
Low -
DevicesFlux Lab Pte. Ltd. d/b/a The Fluxion
FDA warns Flux Lab/The Fluxion over unregistered, unlisted chest binders marketed as medical devices.
Medium -
DevicesMarli Washington Design, LLC
Marli Washington Design (gc2b) sold breast binders as medical devices without FDA registration or listing for FY2026, making them misbranded.
Low -
DevicesFLAVNT Streetwear, LLC
FDA says FLAVNT Streetwear sold breast binders as medical devices without registering or listing them for fiscal 2026.
Low -
DevicesEarly to Bed, Inc.
FDA warned Early to Bed, Inc. that its breast binders are misbranded because the manufacturer was not registered or listed with FDA.
Low -
DevicesGenderBender LLC
GenderBender LLC sells breast binders as medical devices without FDA registration or listing, making them misbranded.
Low -
DevicesTomboyX, PBC
FDA says TomboyX sells breast binders as medical devices without registering or listing them, making them misbranded.
Medium -
DevicesPhiladelphia 7, Inc d/b/a Passional Boutique
FDA says Philadelphia 7 sold unregistered, unlisted breast binders, making them misbranded devices.
Low -
DevicesTOMSCOUT
FDA says TOMSCOUT sells breast binders as medical devices without required FDA registration or listing.
Low -
DevicesFor Them, Inc.
FDA says For Them, Inc. sells breast binders as unregistered medical devices, making them misbranded.
Low -
DevicesShapeShifter Apparel, LLC
FDA says ShapeShifter Apparel sold breast binders as unregistered, unlisted medical devices, making them misbranded.
Low -
DevicesTrans-Missie B.V.
FDA says Trans-Missie B.V. sells breast binders as medical devices without registering or listing them with FDA.
Low -
DrugsMusclepower Enterprise Ltd. dba MONSTER KING and GE LABS
FDA warned Musclepower Enterprise (MONSTER KING/GE LABS) over unapproved SARM drugs and undeclared trendione in GE Labs Ykarine.
High risk -
TobaccoUpper Limits
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsSklar Personal Care Inc.
Sklar Personal Care’s drug facility failed CGMP (current good manufacturing practice), including untested raw materials and inadequate cleaning, process validation, and quality oversight.
High risk -
Tobaccogiantvapes.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccorelevantvapes.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Drugs3D Imaging Drug Design and Development LLC
FDA warns 3D Imaging of CGMP failures in sterile PET drug manufacturing and outdated drug listings.
High risk -
BiologicsGreen Valley Fertility Partners
FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.
High risk -
BiologicsMicrovascular Tissue, Inc.
FDA says Microvascular Tissue's mVASC wound product is an unapproved drug and unlicensed biologic, made without validated processes.
High risk -
FoodHarbor Marine Product Inc.
FDA found Listeria bacteria on raw ready-to-eat fish contact surfaces and serious seafood HACCP and importer verification failures at Harbor Marine Product.
High risk